Abramowicz, Daniel <br/><br/>
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Nov 2008 
 - 3727-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfn332  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Creatinine--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Graft Rejection--epidemiology<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kaplan-Meier Estimate<br/>Kidney--physiopathology<br/>Kidney Transplantation--mortality<br/>Male<br/>Middle Aged<br/>Proteinuria--chemically induced<br/>Retrospective Studies<br/>Risk Factors<br/>Sirolimus--adverse effects<br/>Transplantation, Homologous